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OmpF-Lpp, a model secretory protein, requires both a posttively charged signal sequence and phosphatidylglycerol (PG) for efficient translocation 
across the E. co/i inner membrane. Modification of the signal sequence can, however, remove both these prerequisites for translocation providing 
OmpF-Lpp mutants which undergo either PG and charge dependent or PG and charge independent translocatron. Here we show that positively 
charged membrane interactive compounds (polylysine & doxorubicin) are able to inhibit PG dependent translocatron of the OmpF-Lpp signal 
sequence mutants but not PG independent translocatron. Doxorubicm is also shown to bind more efficiently to liposomes containing increased 
levels of anionic hpid indicatmg that in these assays it may be Inhibiting translocation by preventing electrostatic interaction between the anionic 
lipid head group and the positively charged signal sequences. 
Protein translocation; Phosphatidylglycerol; Signal sequence 
1. INTRODUCTION 
In prokaryotic systems proteins which are not des- 
tined to remain at their site of synthesis are synthesised 
as precursors with a cleavable N-terminal extension or 
signal sequence [l]. The signal sequence has a tripartite 
morphology which consists of a basic N-terminus, a 
central hydrophobic core and a polar C-terminal region 
[2]. Within E. coli efficient translocation of the precur- 
sor requires a number of proteins [3]. One such protein 
is SecA which is found in a cytoplasmic form and bound 
to the cytoplasmic face of the inner membrane. SecA 
may play a role in targeting the precursor to the site of 
translocation and also acts as an ATPase during the 
translocation process [4]. The ATPase activity is de- 
pendent on the presence of the precursor, anionic lipid 
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and the integral membrane proteins SecE/Y. In addition 
evidence has been presented which indicates that the 
translocation process itself is dependent on negatively 
charged lipid [5,6] but the reason for this dependency is 
unknown. 
We have recently investigated the requirement of 
translocation for anionic lipid [7] by using two series of 
OmpF-Lpp signal sequence mutants [8]. Both series 
contained variable numbers of positively charged lysine 
residues (OK, 2K or 4K) at the N-terminal end of the 
signal sequence but in one series the central hydropho- 
bic core region was composed of 8 Leu residues and in 
the other the core contained 9 Leu residues. This gave 
rise to two series of mutants OKSL, 2K8L, 4K8L and 
OK9L. 2K9L, 4K9L. It has been shown that the 8 Leu 
series requires the positively charged N-terminus to be 
present for efficient translocation and the translocation 
efficiency increases with increasing positive charge [8]. 
In addition we recently showed that the translocation 
efficiency of this series is strongly dependent on the 
presence of the anionic lipid phosphatidylglycerol (PG) 
and the PG requirement mimics the charge dependency 
of the translocation pathway [7]. On increasing the 
length of the hydrophobic core by incorporating a gth 
Leu residue both the charge dependency and PG de- 
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pendency of the translocation process are lost. We pos- 
tulated that the PG dependent translocation path in- 
volves an electrostatic interaction between the positively 
charged signal sequence and the anionic lipid 
headgroup [7]. In the case of the 9 Leu series the in- 
crease in the level of hydrophobicity/length of the core 
region is postulated to allow the signal sequence to di- 
rectly interact with the membrane or a component of the 
translocation machinery and does not require the level 
of charge stabilisation seen in the case of the less hydro- 
phobic 8 Leu series. 
Positively charged compounds which have the poten- 
tial to interact with anionic lipid headgroups have previ- 
ously been shown to perturb the efficiency of the 
translocation reaction [9]. Doxorubicin is an anthracy- 
clin glycoside antibiotic which preferentially binds to 
anionic lipid at the membrane interface [lO.l 1] thereby 
impairing processes which are dependent on these lipids 
[13,14]. We have used both this drug and polylysine to 
probe the nature of the PG dependency of transloca- 
tion. 
2. MATERIALS AND METHODS 
2.1. Bucterrul strum and plasmrd;, 
E. coli strain MRE600 [I 51 was used for the isolation of a S-135 
extract [l6] and in addition this stram was used for the preparation 
of inverted inner membrane vesicles with a wild type phospholipid 
composition (19.8% of the total lipid was PC) [5]. Inverted inner 
membrane vesicles with differing levels of acidic phosphohpid were 
isolated from the strain HDLl 1 grown in the presence of OPM tsopro- 
pylthtogalactoside (IPTG) (3.5% of total mner membrane lipid was 
PG) or 60 PM IPTG (I 9.1% PG) as previously described [6]. 
Plasmids 2KSL, 4K8L. 2K91, 4K9L were used for the m vitro 
expression of the OmpF-Lpp mutants 2K8L. 4KgL. 2K9L, 4K9L 
respectively [S]. 
SecA [I 71. and SecB [ 181 were purified as described. [?S]methionme 
(1000 Ci/mmol) was obtained from Amersham. IPTG was obtamed 
from Sigma. 
2.3. In r~tro trunsmptron-trunslation and trunslocutron rractlons 
The in vitro reactions were performed as previously described [5] 
but SP6 polymerase (Pharmacia) was used m the transcription of the 
plasmids at 37°C for 45 mm. The phospholipid content based on Pi 
was determined after phosphohpid extraction, [19]. using thin layer 
chromatography and perchloric acid destruction [20] The chromatog- 
raphy plates were impregnated with 1.2% boric acid in ethanol (1.1) 
and dried before use. The solvent system used was chloroform/metha- 
nol/water/ammomum (25%) (65:37:5:3:1) v/v [21] 
After transcription translation was allowed to contmue for ten mm- 
utes, the mixture was diluted 1:l with 12 M urea in 50 mM sodium 
phosphate buffer pH 7.4. followed by 3 min sonication in a water bath 
to prevent aggregation of the precursor protems [8]. 
The translocation reactions were performed at 37°C as previously 
described [5] but where necessary, prior to the assay, the membrane 
vesicles were incubated for 2 min at 37°C m the translocation assay 
mixture contaming the posttively charged compounds (doxorubicin or 
polylysine). The reaction was only allowed to proceed for 5 min after 
which protemase K was added to digest all of the non-translocated 
protein. After incubating for a further 10 mm at 37°C the protease 
treatment was stopped by the addition of trichloroacetic acid to a final 
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Fig. 1. Doxorubicin bmdmg assay. E colt HDLl I was grown in the 
presence of 0 PM or 60 flM IPTG to produce vesicles containmg 
approximately 5% ( ..I) or 28% (0) of the total lipid as PG and CL. 400 
nm LUVETS were prepared from total lipid extracts and incubated 
with varying concentrations of doxorubicin. The level of doxorubicm 
bound is recorded per hpid phosphate in the sample. All points are 
mean values of experiments performed m duplicate. 
concentration of 15%. After precipitating on ice the samples were 
analysed by tricme SDS-PAGE [22] and fluorography. 
In vitro translocation IS defined as the amount of precursor and 
mature form of the protein remammg after protemase K treatment. 
The level of translocation was quantified by scintillation countmg of 
rehydrated. excised protem bands (precursor and mature) from the 
dried gels 
To calculate translocation efficiency the percentage of the available 
precursor which had translocated across wild type vesicles prepared 
from MRE600 was normalized to 100%. The level of translocation 
observed after the vesicles had been pre-incubated with either polyly- 
sure or doxorubicm was related to thts 100% level 
2.4. Bmdmg esprrrmrrtts 
400 nm. large umlamellar vesicles prepared by extrusion (LUVETS) 
(800~1000 nmol phosphate) [I I], were mixed with variable concentra- 
tions of doxorubicin m a final volume of I ml The buffer used was 
10 mM PIPES. 100 mM NaCI, 0.5 mM EGTA (triplex VI), pH 7.4 
(NaOH). The assay mixture was incubated for 1 and 3 h in the dark 
(both time mtervals gave identical results) at room temperature (20- 
25°C) The LUVETS were pelleted (60 mm, 435,000 x R. Beckman 
TLA100.3) A sample of the supernatant was diluted for determina- 
tion of the equilibrium drug concentration Binding of drug to the 
tubes and the amount of lipid in the supernatant were both negligible. 
3. RESULTS AND DISCUSSION 
Translocation of the OmpF-Lpp signal sequence mu- 
tants containing a hydrophobic core of 8Leu residues 
is dependent on anionic phospholipid [7] and it has been 
postulated that the anionic lipid is electrostatically in- 
teracting with the signal sequence at some stage within 
the translocation pathway. Since doxorubicin is also 
known to interact with membranes containing anionic 
lipid [11,12] we investigated whether doxorubicin bind- 
ing was able to inhibit the translocation process. 
Initially it was necessary to show that there was a 
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Fig. 2. Effect of doxorubicm on translocation. Translocatton assays 
were performed using wild type membrane vestcles (MRE600). The 
effect of doxorubicin on the translocation efficiency of the 2K8L (0) 
and 2K9L (*) signal sequence mutants are shown m (A). (B) shows 
translocatton efficiency of 4K8L (0) and 4K9L (+) in the presence of 
varymg concentrations of doxorubicin. 100% represents weld type 
translocation. Samples were analysed by tncine SDS-PAGE and 
fluorography and quanttfied by scintillatton counting. All pomts arc 
the mean of two to three experiments 
relationship between the doxorubicin interaction at the 
membrane interface and the level of anionic lipid in the 
bilayer. HDLl 1 is an E. coli strain in which the pgsA 
gene encoding phosphatidylglycerol phosphate syn- 
thase has been placed under the control of a lac pro- 
moter. By incubating the bacteria in the presence of 
varying levels of IPTG it is therefore possible to control 
the level of pgsA expression and hence control the level 
of PG and cardiolipin (CL) production [6]. In the ab- 
sence of IPTG the level of anionic lipids within the inner 
membrane was found to be 2% PG and 3% CL based 
on the total phospholipid but incubation in the presence 
of 60 FM IPTG produced cells containing 28% of the 
total lipid as PG and CL. Total lipid extracts from cells 
grown in the presence and absence of IPTG were used 
to produce 400 nm LUVETS [l l] which were incubated 
in the presence of varying doxorubicin concentrations. 
As can be see in Fig. 1 increased levels of anionic lipids 
within the membrane increases the level of doxorubicin 
binding to the LUVETS implying that the doxorubicin 
is interacting preferentially with the anionic lipids, pre- 
sumably via an electrostatic interaction. We then pro- 
ceeded to investigate the effect of doxorubicin on 
translocation of the OmpF-Lpp mutants. Fig. 2 shows 
that in the case of the OmpF-Lpp mutants which re- 
quire PG for translocation, increasing the level of 
doxorubicin inhibits the level of translocation across E. 
coli inner membranes with a wild type lipid composi- 
tion. Importantly the PG independent translocation of 
the 9 Leu OmpF-Lpp mutants was unaffected by the 
level of doxorubicin present and the mutants were able 
to translocate at wild type levels in all cases. 
It has previously been shown that both the 8 and 9 
Leu mutants are SecA dependent [S]. Since the 9 Leu 
precursors can still translocate it would appear that the 
doxorubicin has not incapacitated the Set dependent 
translocation machinery. The binding of doxorubicin to 
biological membranes has also been shown to affect a 
number of membrane associated processes including 
electron transfer [13] and this may therefore affect the 
proton-motive force (pmf) across the membrane. Both 
the 8 and 9 Leu mutants have been shown to undergo 
pmf dependent translocation hence, since the 9 Leu pre- 
cursors translocate, alteration in pmf can not be the 
reason for the inhibition of translocation in the case of 
the 8Leu precursors. A feasible explanation for the ob- 
served inhibition of PG dependent translocation would 
be that the doxorubicin is interacting with anionic lipid 
and thus preventing the lipid participating in the 
translocation reaction. 
Polylysine also has the potential to interact with ani- 
onic lipid and has also been shown to have a inhibitory 
affect on the PG dependent translocation of wild type 
prePhoE [9] hence we wished to observe whether this 
was also the case for the OmpF-Lpp mutants. Vesicles 
were therefore pre-incubated with polylysine prior to 
the translocation assay. As can be seen in Fig. 3 the PG 
dependent translocation reaction undertaken by the 8 
Leu mutants was inhibited yet the PG independent 
translocation of the 9 Leu mutants was able to continue 
irrespective of the level of polylysine present. Further- 
more the level of translocation inhibition seen with 
these mutants is of a similar magnitude to that observed 
in the case of the wild type precursor protein prePhoE 
[9] thus implying that the inhibition of PG dependent 
translocation in this manner is independent of the pro- 
tein studied but is due to the interaction of polylysine 
with a key element in the translocation pathway. We 
believe that this element is the anionic lipid (PG) and 
that the interaction of membrane interactive, positively 
charge compounds with the lipid headgroup prevents 
the participation of this lipid species in translocation. 
In summary, both polylysine and doxorubicin are 
able to inhibit the PG dependent translocation of the 8 
Leu OmpF-Lpp signal sequence mutants but not the PG 
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Fig. 3. Effect of polylysine on the translocation of 2K8L and 2K9L. 
Translocation assays were performed usmg wild type membrane vesi- 
cles (MRE600). The translocation effictencies of 2K8L (0) and 2K9L 
(+) were observed in the presence of varying concentrations of polyly- 
sine. 100% represents wild type translocation. Samples were analysed 
by tricine SDS-PAGE and fluorography and quantified by scintilla- 
tion countmg. All points are the mean of two to three experiments. 
independent translocation of the 9 Leu mutants. Since 
the only known variables in the translocation of these 
two series of mutants are the PG requirement and the 
requirement for positive charges at the amino terminus 
of the signal peptide it is likely that inhibition of the PG 
dependent pathway is due to the electrostatic interac- 
tion of the positively charged compounds with the ani- 
onic lipid head group. It is therefore probable that the 
signal sequence positive charges are directly interacting 
with the lipid in an electrophoretic manner during the 
course of protein translocation. 
Alternatively it may be possible that the signal se- 
quences are differentially interacting with the Set ma- 
chinery thus altering the requirement of the machinery 
for interaction with PG. The fact that directly compara- 
ble levels of translocation inhibition have been seen for 
prePhoE implies that this PG requirement is not only 
specific to these mutants. 
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